A $200 million transaction between owner Serán Bioscience and Bain Capital Life Sciences in 2024 helped support the buildout of the commercial-scale plant.
Categories:
Related Post
GSA accuses Congress of hijacking its building repair fund
The agency has lost the present-day equivalent of $22 billion, fueling a $50 billion maintenance…
AI nears ‘tipping point’ in construction as contractors pilot tech: survey
Beyond a noted optimism, however, over half of surveyed builders expressed concerns about data accuracy…
Ex-Chicago Housing Authority director, builder accused of $4.8M kickback scheme
A former property and asset management official fraudulently awarded construction contracts at CHA properties in…